Starna Therapeutics
Clinical trials sponsored by Starna Therapeutics, explained in plain language.
-
New hope for patients with relapsed leukemia: experimental therapy STR-P004 enters early trial
Disease control Not yet recruitingThis early-phase study tests a new drug called STR-P004 in 11 adults with a type of blood cancer (acute lymphoblastic leukemia) that has come back or not responded to standard treatments. The main goal is to check the drug's safety and find the right dose. Researchers will also l…
Phase: NA • Sponsor: Starna Therapeutics • Aim: Disease control
Last updated May 26, 2026 10:56 UTC
-
New drug aims to calm immune attacks on kidneys
Disease control Not yet recruitingThis early study tests a new drug called STR-P004 in 9 adults with immune-mediated kidney diseases. The goal is to see if the drug is safe and how the body processes it. Participants will receive up to 8 infusions over 1-2 months, with possible dose increases to find the best lev…
Phase: NA • Sponsor: Starna Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:05 UTC